Phibro Animal Health's projected net sales for FY24 are in line with the current estimate. This suggests that the company's financial performance is expected to remain stable, which is generally a positive signal for investors. However, as the forecast is not exceeding the estimate, it may not drive significant stock price movement in the short term.